Optimized oviductal injection protocol for i-GONAD using electric microinjectors

Ohtsuka, Masato, Miyagasako, Rico, Asada, Shun, Yamashita, Aoi, Hashimoto, Kana, Okazaki, Reo, Fujita, Fuki, Yagi, Yusuke, Onuma, Haruno, Sato, Yusuke, Kurosaki, Aki, Katano, Daiki, Szpila, Marcin, Miura, Hiromi, Iwamoto, Takashi, Iwata, Satoru, Gurumurthy, Channabasavaiah B.
Nature Protocols · Springer Nature · 2026-11-20 · DOI: 10.1038/s41596-026-01457-4

Аннотация

This Protocol Extension expands the previously published improved Genome Editing via Oviductal Nucleic Acids Delivery protocol by introducing electric microinjectors for standardized oviductal injection. This extension overcomes the practical challenges involved in using mouth pipetting. The improved Genome Editing via Oviductal Nucleic Acids Delivery ( i -GONAD) method enables the generation of genetically engineered animals by delivering genome-editing reagents to fertilized eggs present in the oviducts of pregnant female mice through in vivo electroporation, without the need to euthanize the female or retrieve embryos for ex vivo manipulations. A key step in this technique involves injecting the solution into the oviduct, which has traditionally been performed using a mouth-operated glass capillary system. However, this method has several practical limitations. First, mouth pipetting is technically demanding, particularly for inexperienced researchers. Specifically, precise control of aspiration and dispensing of very small volumes requires substantial practice. Second, mouth pipetting may not be ideal for maintaining strict specific pathogen-free conditions in some animal facilities. In addition, mouth pipetting may raise biosafety concerns owing to potential exposure of researchers to reagents, which can limit the use of the i -GONAD for delivering biohazardous agents such as viral vectors. Here we optimize and extend the i -GONAD protocol by introducing electric microinjectors as an alternative tool for reagent delivery into the mouse oviduct. We also present optimized injection parameters using this system. The Protocol can be completed in ~2 d, including 1 d for mating and 1 d for the i -GONAD procedure. This timeline does not include the steps performed before the procedure (design and preparation of genome-editing reagents) or after the procedure (analysis of genome-editing outcomes). This Protocol Extension expands the previously published improved Genome Editing via Oviductal Nucleic Acids Delivery protocol by introducing electric microinjectors for standardized oviductal injection and presenting optimized injection parameters using this system.

Читать у издателя →

Похожие статьи